SERES THERAPEUTICS INC shareholders Q2 2023

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 140 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

SERES THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PRUDENTIAL FINANCIAL INC 206,145$987,4350.00%
BNP PARIBAS FINANCIAL MARKETS 154,663$740,8360.00%
GEODE CAPITAL MANAGEMENT, LLC 1,961,358$9,394,9090.00%
BlackRock Finance, Inc. 7,481,227$35,835,0770.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 30,593$146,5400.00%
Cambridge Investment Research Advisors, Inc. 44,844$2150.00%
GOLDMAN SACHS GROUP INC 656,794$3,146,0430.00%
Parallax Volatility Advisers, L.P. 134,901$646,1760.00%
Tower Research Capital LLC (TRC) 4,013$19,2220.00%
CITIGROUP INC 133,200$638,0280.00%
Man Group plc 13,181$63,1370.00%
NEW YORK STATE COMMON RETIREMENT FUND 38,590$1850.00%
PRICE T ROWE ASSOCIATES INC /MD/ 314,427$1,5070.00%
Newbridge Financial Services Group, Inc. 55$2630.00%
Allspring Global Investments Holdings, LLC 1$40.00%
Legal & General Group Plc 86,647$415,0390.00%
Belvedere Trading LLC 900$4,3110.00%
Belvedere Trading LLC 13,000$62,2700.00%
UBS Group AG 73,231$350,7760.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists SERES THERAPEUTICS INC's shareholders in Q2 2023. To view SERES THERAPEUTICS INC's shareholder history, click here.